This inventor holds 1 USPTO granted patent. Top assignee: Arzneimittelerk Dresden G.m.b.h.. Active years: 1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1994
Title: Michael Gutschow: Innovator in Pharmaceutical Chemistry
Introduction
Michael Gutschow is a notable inventor based in Leipzig, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on compounds that have potential therapeutic applications.
Latest Patents
One of Michael Gutschow's key patents is for a compound known as 3-(mercaptoalkyl)quinazoline. This compound or its tautomer is defined by a specific formula where R¹ can be hydrogen or various substituted residues, including 6-methyl, 6-fluoro, 6-chloro, 6-bromo, or 6,7-dimethoxy. This patent highlights his expertise in developing novel chemical entities that may have important uses in medicine.
Career Highlights
Michael Gutschow is associated with Arzneimittelerk Dresden GmbH, where he has been involved in research and development efforts aimed at creating new pharmaceutical products. His work has contributed to advancements in drug formulation and therapeutic efficacy.
Collaborations
Throughout his career, Michael has collaborated with esteemed colleagues such as Siegfried Leistner and Karl Drossler. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Michael Gutschow's contributions to pharmaceutical chemistry, particularly through his patent on 3-(mercaptoalkyl)quinazoline, underscore his role as a significant inventor in the field. His work continues to influence the development of new therapeutic agents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile